Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Current research shows that creatine has a strong biological rationale for supporting neuronal energy production and reducing oxidative stress in Parkinson’s disease but has not been proven to slow clinical progression in large-scale trials. Patients considering creatine should carefully weigh factors such as dosing (typically 5-10 g/day), product purity, kidney function monitoring, and potential interactions with other treatments.
See below for detailed guidance on integrating creatine safely into your Parkinson’s care plan, including laboratory checks, dosing strategies, side effect tracking, and complementary lifestyle measures.
Parkinson's disease is a chronic neurodegenerative disorder marked by tremors, stiffness, slowed movement and balance problems. As researchers explore ways to slow its progression, creatine—a natural compound involved in energy metabolism—has emerged as a potential complementary therapy. This article reviews current evidence on creatine and Parkinson's disease, explains how creatine might work, and offers practical guidance for those considering it.
Creatine is a molecule made in the liver and kidneys and stored mainly in muscles and the brain. It helps recycle adenosine triphosphate (ATP), the energy currency of cells, especially during high-demand activities. People commonly take creatine supplements to improve athletic performance, but growing interest has turned toward its potential neuroprotective effects in conditions like Parkinson's disease.
Researchers have proposed several reasons why creatine might be beneficial:
Mitochondrial support
Mitochondria generate most of the cell's energy. In Parkinson's, mitochondrial dysfunction contributes to neuronal death. Creatine may bolster mitochondrial ATP production, helping brain cells maintain function longer.
Antioxidant effects
Oxidative stress—damage from free radicals—plays a key role in Parkinson's progression. Creatine appears to have mild antioxidant properties, potentially reducing cellular stress.
Cellular energy buffer
By storing high-energy phosphate groups, creatine can buffer energy supply during times of stress, possibly protecting vulnerable dopamine-producing neurons.
Animal models
Studies in rodents treated with Parkinson's-like toxins (e.g., MPTP) showed that creatine reduced signs of neuronal damage and improved motor function.
Cell cultures
In vitro experiments with nerve cells exposed to oxidative stress reported that creatine helped preserve cell viability.
While these studies are promising, animal and cell work do not always translate directly to human benefit.
Multiple human studies have examined creatine and Parkinson's disease:
Phase II trial (small scale)
A pilot study gave participants 10 grams of creatine daily for 6 months. Results showed trends toward slowed decline on some motor assessments, but the study was too small to draw firm conclusions.
Phase III trial (large scale)
The NIH-sponsored "LS-1" trial enrolled over 1,700 early Parkinson's patients, randomizing them to creatine (10 g/day) or placebo for up to 5 years. In 2015, researchers stopped the trial due to futility: creatine did not slow clinical progression compared to placebo.
Safety data
Across trials, creatine was generally well tolerated. Mild side effects included gastrointestinal discomfort and weight gain. Kidney function was monitored carefully; no significant long-term harm to healthy kidneys was observed, though caution is advised for those with preexisting kidney issues.
No proven disease-modifying effect
Large, well-designed clinical trials have not confirmed that creatine slows Parkinson's progression.
Potential benefits remain theoretical
While the biological rationale is strong, human evidence is lacking. Some experts suggest that different dosing regimens or earlier intervention might yield different outcomes, but this remains unproven.
If you're thinking about adding creatine to your routine, keep these points in mind:
Dosage
Most studies used 5–10 grams per day. Higher doses don't necessarily mean better results and may increase side effects.
Form and purity
Choose pharmaceutical-grade creatine monohydrate from reputable suppliers to ensure purity and minimize contaminants.
Monitoring
Before starting, check kidney function with your doctor. Repeat lab tests periodically, especially if you have or develop kidney concerns.
Interactions
Creatine may increase water retention. If you take diuretics or have heart or kidney issues, discuss potential fluid balance changes with your physician.
Overall management
Creatine should never replace standard treatments. It may be considered an adjunct to medication, exercise and physical therapy.
Discuss with your neurologist or movement-disorder specialist.
Share your interest in creatine and review your medical history, including kidney health and current medications.
Establish baseline labs.
Obtain serum creatinine, glomerular filtration rate (GFR) and other routine blood tests to guide safe use.
Start low and monitor.
Begin at 3–5 g/day. If tolerated, you and your doctor can decide whether to increase to 10 g/day.
Track symptoms and side effects.
Keep a simple log of motor symptoms, energy levels and any digestive or fluid-related issues.
Reassess regularly.
Schedule follow-up visits every 3–6 months to review effectiveness and safety.
Creatine is just one piece of the puzzle. Evidence-based strategies for overall Parkinson's support include:
• Regular exercise (aerobic, strength, balance training)
• Mediterranean-style diet rich in antioxidants
• Adequate sleep and stress management
• Standard pharmacological therapies (levodopa, dopamine agonists, MAO-B inhibitors)
• Physical, occupational and speech therapy as needed
Parkinson's symptoms can overlap with other conditions. If you or a loved one notices new or worsening tremors, stiffness, slowness of movement or balance issues, use Ubie's free AI-powered Parkinson's Disease symptom checker to help determine whether your symptoms warrant professional evaluation and what steps to take next.
Always speak to a doctor about any concerning symptoms, potential treatment changes or before starting a new supplement—especially if you have serious or life-threatening conditions.
Research continues, and future studies may clarify whether creatine has a role in Parkinson's disease. In the meantime, informed decision-making and close partnership with your medical team are the best paths forward.
(References)
* Klopstock T, Elger CE, Lehnertz K. Creatine in the treatment of neurodegenerative disorders. Mitochondrion. 2021 Jul;59:133-143.
* Shaltout HA, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Creatine Monohydrate in Parkinson's Disease. JAMA Neurol. 2017 Mar 1;74(3):284-290.
* Kieburtz K, et al. Effect of Creatine Monohydrate on Clinical Symptoms and Neuroimaging Markers of Progression in Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2015 Mar;72(3):315-23.
* NINDS Exploratory Clinical Trial Investigators. The NINDS Exploratory Clinical Trial of Coenzyme Q10 and Creatine in Parkinson's Disease: A Study of the Parkinson Study Group. Arch Neurol. 2012 Aug;69(8):979-86.
* Gualtieri F, et al. Creatine in Parkinson's disease: a review of efficacy and safety. Neuropharmacology. 2011 May;60(6):830-8.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.